In a special comment, Dr Brendan Shaw, the principal of Shawview Consulting, former CEO of MS and and assistant director-general of the IFPMA, says the PBS and Australian pharmaceutical policy have suffered some shocks in the past but nothing compares to COVID-19. …
Latest Video
New Stories
-
GSK out to an early lead in Rare Cancers Australia Kosi Challenge 'Pharma Cup'
February 7, 2025 - - Latest News -
'In an optimal, equitable system, access to evidence-based, cost-effective genomics-guided medicines would be provided to all'
February 7, 2025 - - Latest News -
The 'Dispatched' week in review podcast - 7 February
February 6, 2025 - - Podcast -
Sanofi Ventures joins investors backing Australian radionuclide company
February 6, 2025 - - Australian Biotech -
'One believes things because one has been conditioned to believe them'
February 6, 2025 - - Latest News -
RFK Jr on the cusp of securing his nomination to lead the US health department
February 6, 2025 - - Latest News -
Omico calls for major government-industry support of fundamental change in cancer treatment
February 5, 2025 - - Latest News